Recruiting the Social Contacts of Patients with STI for HIV Screening in Lilongwe, Malawi: Process Evaluation and Assessment of Acceptability
Overview
Authors
Affiliations
Objectives: To explore acceptability of recruiting social contacts for HIV and sexually transmitted infection (STI) screening in Lilongwe, Malawi.
Methods: In this observational study, three groups of 'seed' patients were enrolled: 45 HIV-infected patients with STI, 45 HIV-uninfected patients with STI and 45 community controls, who were also tested for HIV as part of the study. Each seed was given five coupons and asked to recruit up to five social contacts to the STI clinic. Seeds were told the programme for contacts would include HIV testing, STI screening and general health promotion. Seeds were asked to return after 1 month to report on the contact recruitment process. Seeds received $2 for each successfully recruited contact.
Results: Eighty-nine seeds (66%) returned for 1-month follow-up with no difference between the three seed groups (p=0.9). Returning seeds reported distributing most of their coupons (mean=4.1) and discussing each feature of the programme with most contacts-HIV testing (90%), STI screening (87%) and health promotion (91%). Seeds reported discussing their own HIV status with most contacts (52%), with a lower proportion of HIV-infected seeds discussing their HIV status (22%) than HIV-uninfected seeds (81%) or community seeds (64%) (p<0.001). Contact recruitment did not vary with socioeconomic status.
Conclusions: Most seeds distributed all coupons and reported describing all aspects of the programme to most contacts. Patients with STI are able to act as health promoters within their social networks and may be a critical link to increasing STI and HIV status awareness among high-risk groups.
A Systematic Review of HIV Testing Implementation Strategies in Sub-Saharan African Countries.
Mannoh I, Amundsen D, Turpin G, Lyons C, Viswasam N, Hahn E AIDS Behav. 2021; 26(5):1660-1671.
PMID: 34797449 PMC: 9426653. DOI: 10.1007/s10461-021-03518-z.
Matoga M, Hosseinipour M, Jere E, Ndalama B, Kamtambe B, Chasela C J Infect Dis Med. 2018; 3(3).
PMID: 30417175 PMC: 6223304. DOI: 10.4172/2576-1420.1000128.